← Back to Search

Tissue Matrix

DermACELL AWM + Conventional Care for Venous Leg Ulcer

N/A
Waitlist Available
Research Sponsored by LifeNet Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights
No Placebo-Only Group

Summary

This study is a multicenter, randomized, controlled, open-label trial designed to evaluate the safety and efficacy of DermACELL in subjects with a single target chronic venous leg ulcer (VLU).

Eligible Conditions
  • Venous Leg Ulcer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Healing Rate
Secondary study objectives
Time to wound closure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DermACELL AWM + Conventional CareExperimental Treatment1 Intervention
DermACELL AWM, acellular dermal matrix, plus conventional wound care- DermACELL AWM will be applied at the Baseline visit. Conventional wound care will include advanced wound dressings and multilayer compression.
Group II: Conventional CareActive Control1 Intervention
Conventional wound care will include advanced wound dressings and multilayer compression.

Find a Location

Who is running the clinical trial?

LifeNet HealthLead Sponsor
14 Previous Clinical Trials
1,192 Total Patients Enrolled
~14 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top